Primidone

Generic Name
Primidone
Brand Names
Mysoline
Drug Type
Small Molecule
Chemical Formula
C12H14N2O2
CAS Number
125-33-7
Unique Ingredient Identifier
13AFD7670Q
Background

Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures. Primidone was developed by J Yule Bogue and H C Carrington in 1949.

Primidone was granted FDA Approval on 8 March 1954.

Indication

Primidone is commonly indicated for the management of grand mal, psychomotor, and focal epileptic seizures. In addition, it has also been studied and utilized as an effective management of essential tremor.

Associated Conditions
Essential Tremor, Generalized Tonic-Clonic Seizures, Partial-Onset Seizures, Temporal Lobe Epilepsy (TLE)
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath